The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, Intermediate-Grade

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, Intermediate-Grade


High impact information on Lymphoma, Intermediate-Grade


Biological context of Lymphoma, Intermediate-Grade


Anatomical context of Lymphoma, Intermediate-Grade


Gene context of Lymphoma, Intermediate-Grade


  1. Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Clayberger, C., Wright, A., Medeiros, L.J., Koller, T.D., Link, M.P., Smith, S.D., Warnke, R.A., Krensky, A.M. Lancet (1987) [Pubmed]
  2. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. Waxman, A.D., Eller, D., Ashook, G., Ramanna, L., Brachman, M., Heifetz, L., McAndrews, P., Bierman, H., Taub, R., Avedo, M., Wall, F. J. Nucl. Med. (1996) [Pubmed]
  3. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Christensson, B., Tribukait, B., Linder, I.L., Ullman, B., Biberfeld, P. Cancer (1986) [Pubmed]
  4. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Khouri, I.F., Keating, M., Körbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A., Champlin, R. J. Clin. Oncol. (1998) [Pubmed]
  5. Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma. Meyer, R.M., Browman, G.P., Samosh, M.L., Benger, A.M., Bryant-Lukosius, D., Wilson, W.E., Frank, G.L., Leber, B.F., Sternbach, M.S., Foster, G.A. J. Clin. Oncol. (1995) [Pubmed]
  6. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Smaaland, R., Lote, K., Sothern, R.B., Laerum, O.D. Cancer Res. (1993) [Pubmed]
  7. The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. Weber, J.S., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., White, D.E., Rosenberg, S.A. J. Clin. Oncol. (1992) [Pubmed]
  8. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Newman, J.S., Francis, I.R., Kaminski, M.S., Wahl, R.L. Radiology. (1994) [Pubmed]
  9. The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Moore, A.S., Leveille, C.R., Reimann, K.A., Shu, H., Arias, I.M. Cancer Invest. (1995) [Pubmed]
  10. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma. Cunningham, L.M., Chapman, C., Dunstan, R., Bell, M.C., Joske, D.J. Leuk. Lymphoma (2003) [Pubmed]
  11. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity. Yamanaka, N., Harabuchi, Y., Kataura, A. Cancer (1992) [Pubmed]
  12. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Das Gupta, A., Shah, V.I. Hematologic pathology. (1990) [Pubmed]
WikiGenes - Universities